Evidence map›Paper›PMID 34554016›Full record

ArticleJournal of applied physiology (Bethesda, Md. : 1985)2021

Microvascular fluid flow in ex vivo and engineered lungs.

Micha Sam Brickman Raredon, Alexander J Engler, Yifan Yuan, Allison M Greaney, Laura E Niklason

Open access · greenAbstract read
In one paragraph

Article in Journal of applied physiology (Bethesda, Md. : 1985), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Epithelial Reprogramming and Transition during Pulmonary Bioengineering.bioRxiv : the preprint server for biology · 2026
    Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Micha Sam Brickman RaredonDepartment of Biomedical Engineering, Yale University, New Haven, Connecticut.ORCID 0000-0003-1441-6122
Alexander J EnglerDepartment of Biomedical Engineering, Yale University, New Haven, Connecticut.
Yifan YuanVascular Biology and Therapeutics, Yale University, New Haven, Connecticut.
Allison M GreaneyDepartment of Biomedical Engineering, Yale University, New Haven, Connecticut.
Laura E NiklasonDepartment of Biomedical Engineering, Yale University, New Haven, Connecticut.
Yale University · US

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007205 · NIGMS · YALE UNIVERSITY · PI KAZMIERCZAK, BARBARA I · 1985 to 2019
$42.9M
Engineered Tracheal ReplacementsR01HL138540 · NHLBI · YALE UNIVERSITY · PI NIKLASON, LAURA E · 2017 to 2020
$2.5M
Engineered Airway Construct for Cystic Fibrosis Disease ModelingR21EB024889 · NIBIB · YALE UNIVERSITY · PI NIKLASON, LAURA E · 2018 to 2019
$445k
Reverse Engineering the Pulmonary MicrovasculatureF30HL143906 · NHLBI · YALE UNIVERSITY · PI RAREDON, MICHA SAM · 2019 to 2021
$104k
NHLBI NIH HHS F30 HL143906NHLBI NIH HHS R01 HL138540NIBIB NIH HHS R21 EB024889NIGMS NIH HHS T32 GM007205NIH HHS F30HL143906-01A1NIH HHS T32GM007205
6 · The paper itself

Abstract

In recent years, it has become common to experiment with ex vivo perfused lungs for organ transplantation and to attempt regenerative pulmonary engineering using decellularized lung matrices. However, our understanding of the physiology of ex vivo organ perfusion is imperfect; it is not currently well understood how decreasing microvascular barrier affects the perfusion of pulmonary parenchyma. In addition, protocols for lung perfusion and organ culture fluid-handling are far from standardized, with widespread variation on both basic methods and on ideally controlled parameters. To address both of these deficits, a robust, noninvasive, and mechanistic model is needed which is able to predict microvascular resistance and permeability in perfused lungs while providing insight into capillary recruitment. Although validated mathematical models exist for fluid flow in native pulmonary tissue, previous models generally assume minimal intravascular leak from artery to vein and do not assess capillary bed recruitment. Such models are difficult to apply to both ex vivo lung perfusions, in which edema can develop over time and microvessels can become blocked, and to decellularized ex vivo organomimetic cultures, in which microvascular recruitment is variable and arterially perfused fluid enters into the alveolar space. Here, we develop a mathematical model of pulmonary microvascular fluid flow which is applicable in both instances, and we apply our model to data from native, decellularized, and regenerating lungs under ex vivo perfusion. The results provide substantial insight into microvascular pressure-flow mechanics, while producing previously unknown output values for tissue-specific capillary-alveolar hydraulic conductivity, microvascular recruitment, and total organ barrier resistance.

Indexed as

LungMicrovesselsCapillariesPerfusionalveolar barrierdecellularizedlung physiologymicrovasculatureStarling coefficient

Identifiers

PMID34554016
PMCPMC8616606
OpenAlexW3199939213

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.